Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
2014 · International Journal of Infectious Diseases · 23 citations
https://doi.org/10.1016/j.ijid.2014.06.008
T
Tatjana Odrljin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
1.4K
Citations
18
h-index
20
i10-index
Tatjana Odrljin is an academic researcher. The author has contributed to research in topics: Alkaline Phosphatase Research Studies & Pneumonia and Respiratory Infections & Bacterial Infections and Vaccines. The author has an h-index of 18, co-authored 30 publications.
Papers by this author
worksWED-220 BOS-580, a long-acting FGF-21 analogue, treatment shows beneficial changes in the circulating lipidome and improves MASEF score in patients with phenotypic metabolic dysfunction-associated steatohepatitis in a phase 2a randomized, placebo-controlled, 12-week study
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)01561-7
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
2026 · The Lancet · 0 citations
https://doi.org/10.1016/s0140-6736(25)02276-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat